This inventor holds 1 USPTO granted patent. Top assignees: Children's Medical Center Corporation, The General Hospital Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,077 
1 out of 3,080 
Years Active: 2025
Title: The Innovative Contributions of Kathy Oi-Lan Lui
Introduction
Kathy Oi-Lan Lui is a prominent inventor based in Boston, MA. He has made significant contributions to the field of biotechnology, particularly in the area of gene expression modulation. His work has implications for various medical applications, including treatments for heart conditions and cancer.
Latest Patents
Kathy Oi-Lan Lui holds 1 patent for his invention titled "Efficient protein expression in vivo using modified RNA (mod-RNA)." This invention focuses on synthetic, modified RNAs and their application in vivo to modulate gene expression. The invention also explores the use of these synthetic, modified RNAs in myocytes, cardiomyocytes, and tumors, showcasing its potential in advancing medical therapies.
Career Highlights
Throughout his career, Kathy Oi-Lan Lui has worked with notable institutions, including The General Hospital Corporation and Children's Medical Center Corporation. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the medical field.
Collaborations
Kathy has collaborated with esteemed colleagues such as Kenneth R. Chien and Leon M. Ptaszek. These partnerships have further enriched his research and innovation efforts.
Conclusion
Kathy Oi-Lan Lui's work exemplifies the intersection of innovation and medical science. His contributions to the field of biotechnology continue to pave the way for advancements in gene therapy and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile